血清牛磺胆酸高水平与药物性肝损伤的严重程度和缓解相关
这项前瞻性研究纳入95例药物性肝损伤(DILI)患者,并与100名健康对照和105例慢性乙型肝炎(CHB)对照比较。血清牛磺胆酸(TCA)水平变化与DILI严重程度及生化缓解独立相关,且TCA≥1955.41 nmol/L联合年龄和DILI严重程度可预测6个月时生化异常。肝组织BSEP表达降低而非ABCB11基因变异与胆汁酸谱改变相关。
要点
- DILI患者中37种胆汁酸有30种与健康对照存在显著差异。
- TCA水平变化是DILI生化缓解的独立相关因素。
- TCA≥1955.41 nmol/L联合年龄和严重程度预测6个月生化异常的AUC为0.81。
核心结论
- 血清TCA水平与DILI的严重程度和临床缓解相关。
- 肝组织BSEP蛋白表达降低而非ABCB11基因变异与血清胆汁酸谱改变相关。
研究设计与样本
- 前瞻性研究纳入95例DILI患者(中位年龄53岁,女性73.7%),于2018年8月至2019年8月开展。
- 按年龄、性别和体重指数匹配100名健康对照和105例慢性乙型肝炎(CHB)对照。
- 采用高效液相色谱-串联质谱法测定血清胆汁酸水平。
- 对ABCB11全部27个外显子测序,并用免疫组化分析肝活检标本中BSEP表达。
主要发现
- 分析的37种胆汁酸中有30种在DILI患者与健康对照间存在显著差异。
- 牛磺胆酸(TCA)、甘胆酸、牛磺鹅去氧胆酸和甘氨鹅去氧胆酸水平变化与胆红素升高及DILI严重程度增加相关,也与CHB相关。
- Cox回归分析显示仅TCA水平变化与DILI生化缓解独立相关。
- TCA水平(≥1955.41 nmol/L)联合患者年龄和DILI严重程度与DILI发病后6个月血液生化异常相关(曲线下面积0.81;95%CI 0.71-0.88;敏感度0.69;特异度0.81)。
- ABCB11错义变异与血清胆汁酸谱差异、DILI严重程度或临床缓解无关。
关键数值与推荐
- TCA阈值≥1955.41 nmol/L联合年龄和DILI严重程度预测6个月生化异常:AUC 0.81(95%CI 0.71-0.88),敏感度0.69,特异度0.81。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Alterations in the serum levels of bile acids are associated with drug-induced liver injury (DILI). We investigated the association between serum levels of bile acids and the severity and outcome of DILI, along with the potential role of variants in the ATP binding cassette subfamily B member 11 (ABCB11) gene and expression of its product, ABCB11 (also called BSEP). METHODS: We performed this prospective study of 95 patients (median age, 53 years; 73.7% female) with DILI from August 2018 through August 2019. Patients were matched for age, gender, and body mass index with healthy individuals (n = 100; healthy controls) and patients with chronic hepatitis B (n = 105; CHB controls). We collected demographic and biochemical data at baseline and 1 week, 1 month, 3 months, and 6 months after DILI onset and at the time of biochemical recovery, liver failure or liver transplantation. Serum levels of bile acids were measured using high-performance liquid-chromatography tandem mass-spectrometry. All 27 exons of ABCB11 were sequenced and expression of BSEP was analyzed by immunohistochemistry in liver biopsy specimens. RESULTS: Levels of 30 of the 37 bile acids analyzed differed significantly between patients with DILI and healthy controls. Changes in levels of taurocholic acid (TCA), glycocholic acid, taurochenodeoxycholate, and glycochenodeoxycholate associated with the increased levels of bilirubin and greater severity of DILI, and were also associated with CHB. Cox regression analysis showed that only change in the levels of TCA independently associated with biochemical resolution of DILI. Combination of TCA level (≥ 1955.41 nmol/L), patient age, and DILI severity was associated with abnormal blood biochemistry at 6 months after DILI onset (area under the curve, 0.81; 95% confidence interval, 0.71-0.88; sensitivity, 0.69; specificity, 0.81). ABCB11 missense variants were not associated with differences in the serum bile acid profiles, DILI severity, or clinical resolution. However, lower levels of BSEP in bile canaliculi in liver biopsies were associated with altered serum levels of bile acids. CONCLUSIONS: In this prospective study performed in Chinese patients, we found that the serum levels of TCA were associated with the severity and clinical resolution of DILI. Reduced protein expression of BSEP in liver tissue, rather than variants of the ABCB11 gene were associated with altered serum levels of bile acids.
引用
- Tian Q, Yang R, Wang Y, et al. A High Serum Level of Taurocholic Acid Is Correlated With the Severity and Resolution of Drug-induced Liver Injury. Clin Gastroenterol Hepatol. 2020. PMID: 32634627. doi:10.1016/j.cgh.2020.06.067
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。